Immediate Impact
1 from Science/Nature 64 standout
Citing Papers
The therapeutic potential of circular RNAs
2025 Standout
Trials and Tribulations of MicroRNA Therapeutics
2024 Standout
Works of Allen Poma being referenced
101HEMB01 Is a Phase 1/2 Open-Label, Single Ascending Dose-Finding Trial of DTX101 (AAVrh10FIX) in Patients with Moderate/Severe Hemophilia B That Demonstrated Meaningful but Transient Expression of Human Factor IX (hFIX)
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Allen Poma | 297 | 167 | 62 | 20 | 410 | |
| Lorraine Baltzer | 121 | 48 | 79 | 16 | 337 | |
| W. Henwood Harvey | 275 | 76 | 37 | 12 | 363 | |
| Eva Neunhoeffer | 61 | 62 | 49 | 15 | 395 | |
| P. Dormann | 48 | 46 | 127 | 14 | 409 | |
| M Berger | 120 | 43 | 34 | 19 | 380 | |
| Courtney Shea | 141 | 131 | 88 | 16 | 426 | |
| J. F. Costello | 61 | 166 | 62 | 14 | 388 | |
| Debra Smith | 268 | 66 | 24 | 17 | 453 | |
| Hatem Azzouz | 68 | 100 | 95 | 37 | 352 | |
| Norman O. Rothermich | 72 | 34 | 47 | 25 | 417 |
All Works
Loading papers...